[HTML][HTML] Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update

A Sharma, S Ahmed, J Kaur, R Chawla, C Rejeeth - Virusdisease, 2021 - Springer
COVID-19 outburst initiated from the city of Wuhan in China in December 2019 and has
been declared as a public health emergency of international concern. This pandemic …

[HTML][HTML] Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for …

TK Mackey, VJ Schoenfeld - BMC medicine, 2016 - Springer
Social media is fundamentally altering how we access health information and make
decisions about medical treatment, including for terminally ill patients. This specifically …

AIDS activists, FDA regulation, and the amendment of America's Drug Constitution

LA Grossman - American Journal of Law & Medicine, 2016 - cambridge.org
The Parklawn Building, a massive, bland edifice erected in the late 1960s, looms over a
neighborhood of nondescript office buildings and auto repair shops in Rockville, Maryland …

[图书][B] Medical liability and treatment relationships

MA Hall, D Orentlicher, MA Bobinski, N Bagley… - 2018 - books.google.com
Medical Liability and Treatment Relationships is based on Part I, The Provider and the
Patient, of parent book Health Care Law and Ethics, and adds additional coverage of …

No Need for More Regulation: Payors and Their Role in Balancing the Cost and Safety Considerations of Off-Label Prescriptions

AE Todd - American Journal of Law & Medicine, 2011 - journals.sagepub.com
In 2009, health care expenditures in the United States totaled $2.5 trillion and accounted for
almost eighteen percent of the national Gross Domestic Product (GDP). 1 Rising health care …

At the end of the clinical trial: Does access to investigational technology end as well

RS Saver - W. New Eng. L. Rev., 2009 - HeinOnline
Investigational medical technology presents difficult questions for health law and policy
regarding access. Patients and health care providers often want to use experimental drugs …

[HTML][HTML] Permitting patients to pay for participation in clinical trials: the advent of the P4 trial

D Shaw, G De Wert, W Dondorp, D Townend… - Medicine, Health Care …, 2017 - Springer
In this article we explore the ethical issues raised by permitting patients to pay for
participation (P4) in clinical trials, and discuss whether there are any categorical objections …

Regulation of Drugs: A Death Sentence for the Terminally Ill

P Brandes - USFL Rev., 2011 - HeinOnline
THE US FOOD and drug Administration (" FDA") has long served as a regulator for new
pharmaceuticals that are seeking introduction into interstate commerce. It ensures that …

Fighting for the Right to Try: Testing the DC Circuit's Reasoning in Abigail Alliance in Light of Obergefell

BM Gardner - Admin. L. Rev., 2018 - HeinOnline
Matthew Bellina was flying an EA-6B Prowler out of Naval Air Station Whidbey Island on
Washington's Puget Sound when he started twitching and losing coordination. 1 Bellina …

Plan B: access to emergency contraception in the legal and political cross hairs

IG Cohen, L Sullivan, EY Adashi - Contraception, 2013 - contraceptionjournal.org
The 8-year legal feud over access to emergency contraception between reproductive health
advocates and the Food and Drug Administration (FDA) took multiple unexpected turns …